CHIANG-NGERNTHANYAKUN, K. Romosozumab: New anti-osteoporosis agent approved by food and drug administration of the United States. Mahidol Dental Journal, Bangkok, Thailand, v. 39, n. 3, p. 181–197, 2019. Disponível em: https://he02.tci-thaijo.org/index.php/mdentjournal/article/view/204508. Acesso em: 1 oct. 2026.